Posts filed under ‘biotech firm’

After Hours: Intermune Shares Zoom 80% Lower in Late Trade …

A lung treatment by the biotech firm is unable to win approval from US regulators, prompting a sell-off in the company’s shares late Tuesday.
Continued

May 5, 2010 at 10:30 pm Leave a comment


Calendar

September 2017
M T W T F S S
« Aug    
 123
45678910
11121314151617
18192021222324
252627282930  

Posts by Month

Posts by Category